{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:24:07Z","timestamp":1787847847431,"version":"build-2784847793"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic>\n                      with AmpC \u03b2-lactamase are multidrug-resistant organisms and represent a significant challenge to patient care. This study aims to determine the prevalence of plasmid-derived AmpC \u03b2-lactamase among extended spectrum \u03b2-lactamases (ESBL)-producing\n                      <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic>\n                      strains in Bahrain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      It was a cross-sectional study. A total of 185 ESBL-producing\n                      <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic>\n                      isolates were recovered from clinically significant specimens from January 2018 to December 2019. The samples underwent initial screen for cefoxitin resistance by disc diffusion test and subsequent phenotypic confirmation of AmpC production with phenyl boronic acid assays as well as genotypic analysis by multiplex polymerase chain reactions for AmpC subtypes. Drug-resistant features of these clinical isolates were also examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Twenty-nine ESBL-producing\n                      <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic>\n                      isolates were cefoxitin resistant. Phenotypic and genotypic analyses confirmed that 8 and 12 cefoxitin-resistant isolates are AmpC positive, respectively. These AmpC producers are multidrug resistant, and Escherichia coli is the dominant strain among them.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      Plasmid-mediated spread of AmpC is present in clinically relevant\n                      <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic>\n                      species in Bahrain. Rational antimicrobial therapy against these multidrug-resistant organisms and continued surveillance of antimicrobial resistance mechanisms among the clinical isolates are recommended for optimal patient care.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/atm.atm_523_20","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T10:13:20Z","timestamp":1613643200000},"page":"287-293","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Molecular detection of plasmid-derived AmpC \u03b2-lactamase among clinical strains of Enterobacteriaceae in Bahrain"],"prefix":"10.4103","volume":"16","author":[{"given":"Ronni Mol","family":"Joji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ebrahim","family":"Al-Mahameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamer Al","family":"Jishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania Ismail","family":"Fatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin K.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Jaradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Mubarak","family":"Bindayna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0974-2727.129082","article-title":"Detection of AmpC \u03b2 Lactamases in Gram-negative Bacteria","volume":"6","author":"Gupta","year":"2014","journal-title":"J Lab Physicians"},{"key":"R3-10-20240830","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/INF.0b013e31823c0e47","article-title":"Review of carbapenemases and AmpC-beta lactamases","volume":"30","author":"Marsik","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R4-10-20240830","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ajic.2006.05.238","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae","volume":"34","author":"Paterson","year":"2006","journal-title":"Am J Infect Control"},{"key":"R5-10-20240830","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"R6-10-20240830","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R7-10-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","article-title":"Plasmid-determined AmpC-type beta-lactamases","volume":"46","author":"Philippon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R8-10-20240830","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jac\/dkg284","article-title":"AmpC beta-lactamases: what do we need to know for the future?","volume":"52","author":"Hanson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"R9-10-20240830","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0255-0857.99489","article-title":"Detection of Amp C genes encoding for beta-lactamases in Escherichia coli and Klebsiella pneumoniae","volume":"30","author":"Shanthi","year":"2012","journal-title":"Indian J Med Microbiol"},{"key":"R10-10-20240830","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/apm.12631","article-title":"Extended spectrum cephalosporin resistance among clinical isolates of Enterobacteriaceae in West Norway during 2006-2013; a prospective surveillance study","volume":"125","author":"Mylvaganam","year":"2017","journal-title":"APMIS"},{"key":"R11-10-20240830","doi-asserted-by":"crossref","first-page":"ofz353","DOI":"10.1093\/ofid\/ofz353","article-title":"Molecular epidemiology of ceftriaxone non-susceptible enterobacterales isolates in an Academic Medical Center in the United States","volume":"6","author":"Tamma","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R12-10-20240830","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1099\/jmm.0.000504","article-title":"Prevalence study of plasmid-mediated AmpC \u03b2-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals","volume":"66","author":"Abdalhamid","year":"2017","journal-title":"J Med Microbiol"},{"key":"R14-10-20240830","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0971-5916.93433","article-title":"Molecular description of plasmid-mediated AmpC \u03b2-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different hospitals in India","volume":"135","author":"Mohamudha","year":"2012","journal-title":"Indian J Med Res"},{"key":"R15-10-20240830","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jgar.2020.03.011","article-title":"High prevalence of blaCMY AmpC beta-lactamase in ESBL co-producing Escherichia coli and Klebsiella spp. clinical isolates in the northeast of Iran","volume":"22","author":"Rizi","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"R16-10-20240830","first-page":"359","article-title":"Phenotypic & molecular characterization of AmpC \u03b2-lactamases among Escherichia coli, Klebsiella spp.& Enterobacter spp. from five Indian Medical Centers","volume":"135","author":"Manoharan","year":"2012","journal-title":"Indian J Med Res"},{"key":"R17-10-20240830","first-page":"29","article-title":"Occurrence & detection of AmpC beta-lactamases at a referral hospital in Karnataka","volume":"118","author":"Ratna","year":"2003","journal-title":"Indian J Med Res"},{"key":"R18-10-20240830","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1469-0691.2009.02756.x","article-title":"Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory","volume":"16","author":"Pitout","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R19-10-20240830","first-page":"117","article-title":"Heat treatment of bacteria: A simple method of DNA extraction for molecular techniques","volume":"41","author":"Dashti","year":"2009","journal-title":"Kuwait Med J"},{"key":"R20-10-20240830","first-page":"DC05","article-title":"Enhancing phenotypic detection of ESBL in AmpC co-producers by using cefepime and tazobactam","volume":"10","author":"Kaur","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R21-10-20240830","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.phrp.2015.02.001","article-title":"High prevalence of AmpC \u03b2-lactamases in clinical isolates of Escherichia coli in Ilam, Iran","volume":"6","author":"Maleki","year":"2015","journal-title":"Osong Public Health Res Perspect"},{"key":"R22-10-20240830","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijantimicag.2008.07.025","article-title":"High resistance to fourth-generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases isolated in Portugal","volume":"33","author":"Fernandes","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"R23-10-20240830","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0255-0857.108723","article-title":"Detection of plasmid-mediated AmpC \u03b2-lactamase in Escherichia coli and Klebsiella pneumoniae","volume":"31","author":"Yilmaz","year":"2013","journal-title":"Indian J Med Microbiol"},{"key":"R24-10-20240830","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0377-4929.118686","article-title":"Evaluation of phenotypic tests for the detection of AmpC beta-lactamase in clinical isolates of Escherichia coli","volume":"56","author":"Handa","year":"2013","journal-title":"Indian J Pathol Microbiol"},{"key":"R26-10-20240830","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mjafi.2012.02.001","article-title":"Therapeutic challenges of ESBLS and AmpC beta-lactamase producers in a tertiary care center","volume":"69","author":"Grover","year":"2013","journal-title":"Med J Armed Forces India"},{"key":"R27-10-20240830","first-page":"76","article-title":"Prevalence of ESBL, AmpC and carbapenemase among Gram-negative bacilli isolated from clinical specimens","volume":"2","author":"Doddaiah","year":"2014","journal-title":"Am J Life Sci"},{"key":"R28-10-20240830","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1874285801711010195","article-title":"Co-Occurrence of plasmid-mediated AmpC \u03b2-lactamase activity among Klebsiella pneumoniae and Escherichia coli","volume":"11","author":"Zorgani","year":"2017","journal-title":"Open Microbiol J"},{"key":"R29-10-20240830","doi-asserted-by":"crossref","first-page":"e0113033","DOI":"10.1371\/journal.pone.0113033","article-title":"Plasmid-mediated AmpC: prevalence in community-acquired isolates in Amsterdam, the Netherlands, and risk factors for carriage","volume":"10","author":"Reuland","year":"2015","journal-title":"PLoS One"},{"key":"R30-10-20240830","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/medicina55060272","article-title":"ESBL and AmpC \u03b2-lactamases in clinical strains of Escherichia coli from Serra da Estrela, Portugal","volume":"55","author":"Oliveira","year":"2019","journal-title":"Medicina (Kaunas"},{"key":"R31-10-20240830","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jac\/dkl456","article-title":"Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland","volume":"59","author":"Woodford","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R32-10-20240830","doi-asserted-by":"crossref","first-page":"e8556","DOI":"10.5812\/jjm.8556","article-title":"Genotypic Identification of AmpC \u03b2-lactamases production in Gram-negative Bacilli Isolates","volume":"7","author":"Wassef","year":"2014","journal-title":"Jundishapur J Microbiol"},{"key":"R33-10-20240830","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1099\/jmm.0.029140-0","article-title":"Comparison of methods for AmpC \u03b2-lactamase detection in Enterobacteriaceae","volume":"60","author":"Ingram","year":"2011","journal-title":"J Med Microbiol"},{"key":"R34-10-20240830","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/jgid.jgid_68_18","article-title":"Prevalence and characterization of carbapenemase-producing Escherichia coli from a Tertiary Care Hospital in India","volume":"11","author":"Govindaswamy","year":"2019","journal-title":"J Glob Infect Dis"},{"key":"R35-10-20240830","first-page":"181","article-title":"Multidrug resistant AmpC \u03b2-lactamase producing Escherichia coli isolated from a paediatric hospital","volume":"30","author":"Jameel","year":"2014","journal-title":"Pak J Med Sci"},{"key":"R36-10-20240830","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1600-0463.2010.02663.x","article-title":"Prevalence and resistance patterns of extended-spectrum and AmpC \u03b2-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital","volume":"118","author":"Park","year":"2010","journal-title":"APMIS"},{"key":"R37-10-20240830","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1128\/AAC.44.9.2534-2536.2000","article-title":"Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles","volume":"44","author":"Mart\u00ednez-Mart\u00ednez","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-10-20240830","doi-asserted-by":"crossref","first-page":"66","DOI":"10.11604\/pamj.2017.27.66.10226","article-title":"Multi-antibiotic resistant extended-spectrum beta-lactamase producing bacteria pose a challenge to the effective treatment of wound and skin infections","volume":"27","author":"Oli","year":"2017","journal-title":"Pan Afr Med J"},{"key":"R39-10-20240830","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1995-7645(11)60222-8","article-title":"High prevalence of blaCTX-M in Enterobacteriaceae isolates from the Kingdom of Bahrain","volume":"4","author":"Bindayna","year":"2011","journal-title":"Asian Pac J Trop Med"},{"key":"R40-10-20240830","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/1348-0421.12104","article-title":"Molecular characterization of the \u03b2-lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia","volume":"57","author":"Marie","year":"2013","journal-title":"Microbiol Immunol"},{"key":"R41-10-20240830","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/cid\/cix034","article-title":"The use of noncarbapenem \u03b2-lactams for the treatment of extended-spectrum \u03b2-lactamase infections","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.ATM_523_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:41:09Z","timestamp":1787845269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.ATM_523_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/atm.atm_523_20","relation":{},"ISSN":["1817-1737"],"issn-type":[{"value":"1817-1737","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}